CTN pharmacotherapy trials and the CTP.

This presentation describes the growth and diverse characteristics of the CTN community treatment provider network (CTPs), a network that began with only 52 participants in 2000 is has now grown to 187 in 2010. CTPs in the CTN typically fall into one of two categories: those offering medication-assisted treatments (methadone/harm reduction) and those that do not (“drug free” clinics). To date, there have been ten medication-based trials in the CTN, 6 involving Suboxone, 2 involving methylphenidate, and 1 each using nicotine patches and bupropion.

The presentation describes many of these protocols, focusing in particular on the impact participation in medication-assisted treatment trials has had on CTP use of agonist replacement medications in general. The positive outcomes of such participation are described, as well as considerations for future research.